Intangible Assets and Goodwill

9 Months Ended

Sep. 29, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2012. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner if warranted, as was the case for certain indefinite lived intangible assets in 2013.



(Dollars in Millions)	September 29, 2013		December 30, 2012
Intangible assets with definite lives:
Patents and trademarks — gross	$	8,953	8,890
Less accumulated amortization	3,789		3,416
Patents and trademarks — net	5,164		5,474
Customer relationships and other intangibles — gross	18,810		18,755
Less accumulated amortization	4,645		4,030
Customer relationships and other intangibles — net	14,165		14,725
Intangible assets with indefinite lives:
Trademarks	7,634		7,648
Purchased in-process research and development	1,504		905
Total intangible assets with indefinite lives	9,138		8,553
Total intangible assets — net	$	28,467	28,752

Goodwill as of September 29, 2013 was allocated by segment of business as follows:



(Dollars in Millions)	Consumer		Pharm	Med Dev & Diag	Total
Goodwill, net at December 30, 2012	$	8,519	1,792	12,113	22,424
Acquisitions	80		247	11	338
Currency translation/Other	18		15	57	90
Goodwill, net as of September 29, 2013	$	8,617	2,054	12,181	22,852

The weighted average amortization periods for patents and trademarks and customer relationships and other intangible assets are 17 years and 24 years, respectively. The amortization expense of amortizable intangible assets was $980 million and $866 million for the fiscal nine months ended September 29, 2013 and September 30, 2012, respectively. The estimated amortization expense for the five succeeding years approximates $1,300 million, before tax, per year. Amortization expense is included in cost of products sold.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details